title: ACCF/AHA methodology for the development of quality measures for cardiovascular technology: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures.
abstract: Consistent with the growing national focus on healthcare quality, the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) have taken a leadership role over the past decade in developing measures of the quality of cardiovascular care by convening a joint ACCF/AHA Task Force on Performance Measures. The Task Force is charged with identifying the clinical topics appropriate for the development of performance measures and with assembling writing committees composed of clinical and methodological experts in collaboration with appropriate subspecialty societies. The Task Force has also created methodology documents that offer guidance in the development of process, outcome, composite, and efficiency measures. Cardiovascular performance measures using existing ACCF/AHA methodology are based on Class I or Class III guidelines recommendations, usually with Level A evidence. These performance measures, based on evidence-based ACCF/AHA guidelines, remain the most rigorous quality measures for both internal quality improvement and public reporting. However, many of the tools for diagnosis and treatment of cardiovascular disease involve advanced technologies, such as cardiac imaging, for which there are often no underlying guideline documents. Because these technologies affect the quality of cardiovascular care and also have the potential to contribute to cardiovascular health expenditures, there is a need for more critical assessment of the use of technology, including the development of quality and performance measures in areas in which guideline recommendations are absent. The evaluation of quality in the use of cardiovascular technologies requires consideration of multiple parameters that differ from other healthcare processes. The present document describes methodology for development of 2 new classes of quality measures in these situations, appropriate use measures and structure/safety measures. Appropriate use measures are based on specific indications, processes, or parameters of care for which high level of evidence data and Class I or Class III guideline recommendations may be lacking but are addressed in ACCF appropriate use criteria documents. Structure/safety measures represent measures developed to address structural aspects of the use of healthcare technology (e.g., laboratory accreditation, personnel training, and credentialing) or quality issues related to patient safety when there are neither guidelines recommendations nor appropriate use criteria. Although the strength of evidence for appropriate use measures and structure/safety measures may not be as strong as that for formal performance measures, they are quality measures that are otherwise rigorously developed, reviewed, tested, and approved in the same manner as ACCF/AHA performance measures. The ultimate goal of the present document is to provide direction in defining and measuring the appropriate use-avoiding not only underuse but also overuse and misuse-and proper application of cardiovascular technology and to describe how such appropriate use measures and structure/safety measures might be developed for the purposes of quality improvement and public reporting. It is anticipated that this effort will help focus the national dialogue on the use of cardiovascular technology and away from the current concerns about volume and cost alone to a more holistic emphasis on value.
authors.forename: Robert O
authors.initials: RO
authors.lastname: Bonow
authors.forename: Pamela S
authors.initials: PS
authors.lastname: Douglas
authors.forename: Alfred E
authors.initials: AE
authors.lastname: Buxton
authors.forename: David J
authors.initials: DJ
authors.lastname: Cohen
authors.forename: Jeptha P
authors.initials: JP
authors.lastname: Curtis
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Delong
authors.forename: Joseph P
authors.initials: JP
authors.lastname: Drozda
authors.forename: T Bruce
authors.initials: TB
authors.lastname: Ferguson
authors.forename: Paul A
authors.initials: PA
authors.lastname: Heidenreich
authors.forename: Robert C
authors.initials: RC
authors.lastname: Hendel
authors.forename: Frederick A
authors.initials: FA
authors.lastname: Masoudi
authors.forename: Eric D
authors.initials: ED
authors.lastname: Peterson
authors.forename: Allen J
authors.initials: AJ
authors.lastname: Taylor
mesh_terms: D000572:American Heart Association; D002309:Cardiology / Q000592:standards*; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000628:therapy*; D003935:Diagnostic Techniques, Cardiovascular / Q000592:standards*; D006801:Humans; D017410:Practice Guidelines as Topic / Q000592:standards; D011785:Quality Assurance, Health Care / Q000379:methods* / Q000592:standards*; D014481:United States